semaglutide monograph Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes Wegovy 0.25 mg/0.5 mL pre-filled

Ozempic (semaglutide) is an injectable medication approved for the treatment of Type 2 diabetes

Results Among 75,497 adverse events from 28,403 patients, 442 (0.58%) were linked to benign and malignant neoplasms

Common side effects include gastrointestinal symptoms

Historical reason: the original 503A and 503B compounding pharmacies that started compounding semaglutide in 2022 used B12 as a "marker" so patients and providers could visually distinguish their compounded product from FDA-approved Ozempic, which is always clear

Dulaglutide, meanwhile, is an established type 2 diabetes drug sold by Eli Lilly and Company under the brand name Trulicity

But there does seem to be some data to suggest that they might be. What Is NAION